Decent Medipharm

Maball (rituximab) 500mg injection is a monoclonal antibody used to treat several conditions, including non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. It works by targeting and marking specific cells (B-cells) for destruction by the immune system or by reducing inflammation in autoimmune diseases. The treatment is administered in a hospital or clinic by a healthcare professional. 

Mabtas 500mg (Rituximab) is an intravenous infusion used to treat certain cancers and autoimmune disorders. It is a targeted therapy administered by a healthcare professional in a hospital or clinic setting. 

Maball 100mg Injection is a form of rituximab used to treat certain cancers and autoimmune disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. The treatment involves intravenous (IV) infusion and is only administered by a qualified healthcare professional, not self-administered. 

The 500mg Mabtas RA Rituximab Injection is a treatment for rheumatoid arthritis (RA), a condition it manages by targeting and reducing the immune system's response, which in turn decreases inflammation, pain, and joint damage. It also treats certain blood cancers like non-Hodgkin's lymphoma and chronic lymphocytic leukemia, as well as other autoimmune diseases such as granulomatosis with polyangiitis and microscopic polyangiitis. The injection works by depleting B lymphocytes, a type of immune cell, which helps to control the disease progression. 

The 500mg Enfiera Rituximab Injection is a prescription medication used to treat certain types of cancer (like non-Hodgkin lymphoma and chronic lymphocytic leukemia) and autoimmune diseases (such as rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris). It works by targeting and killing specific B-cells, which reduces inflammation in autoimmune conditions and slows cancer cell growth. This treatment must be administered by a healthcare professional, who will determine the correct dosage and schedule based on the specific condition being treated. 

100mg Mabtas Rituximab concentrate injections are used to treat various cancers, including non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL), and certain autoimmune diseases like rheumatoid arthritis, granulomatosis with polyangiitis, and pemphigus vulgaris. The treatment works by targeting and attaching to the CD20 protein on certain blood cells, which helps inhibit cancer cell growth and modulates the immune response in autoimmune conditions. It is administered as an intravenous infusion, which may require the use of other chemotherapy agents for some conditions.